Loading…
Atrophic and Microcystic Limited Prostatic Adenocarcinomas
Atrophic carcinoma and microcystic carcinoma have previously been classified as variants of conventional acinar adenocarcinoma. In this article, we studied 4 cases of atrophic carcinoma and 4 cases of limited microcystic carcinoma. We found an incidence of 0.8% in 250 needle prostatic biopsies and 1...
Saved in:
Published in: | International journal of surgical pathology 2020-09, Vol.28 (6), p.584-589 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | cdi_FETCH-LOGICAL-c318t-b22a7fd8d06866cd15a1a93c9edc27aac11282f50c5cd10d71c0d98c0d95167e3 |
container_end_page | 589 |
container_issue | 6 |
container_start_page | 584 |
container_title | International journal of surgical pathology |
container_volume | 28 |
creator | Arista-Nasr, Julian Martinez-Benitez, Braulio Mendez-Cano, Victor Albores-Saavedra, Jorge |
description | Atrophic carcinoma and microcystic carcinoma have previously been classified as variants of conventional acinar adenocarcinoma. In this article, we studied 4 cases of atrophic carcinoma and 4 cases of limited microcystic carcinoma. We found an incidence of 0.8% in 250 needle prostatic biopsies and 1.3% of atrophic carcinoma in 150 radical prostatectomies. Microcystic carcinomas were found in 3 prostatectomies (1.2%) and in 1 needle biopsy (0.67%). The useful histological criteria for atrophic carcinoma included the irregular disposition of the glands, infiltrative pattern, “rigid” luminal borders, and intraluminal secretions. Cytological changes included scant cytoplasm, nucleomegaly, hyperchromatic nuclei, and visible nucleoli. The glands of the microcystic carcinoma differ from the benign glands because the malignant ones show a markedly greater dilatation and exhibit rigidity of glandular lumens. In some cases of microcystic carcinoma, the nuclei were flattened, small, and hyperchromatic; therefore, they can be difficult to recognize as malignant. |
doi_str_mv | 10.1177/1066896920911087 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2385713859</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_1066896920911087</sage_id><sourcerecordid>2424879928</sourcerecordid><originalsourceid>FETCH-LOGICAL-c318t-b22a7fd8d06866cd15a1a93c9edc27aac11282f50c5cd10d71c0d98c0d95167e3</originalsourceid><addsrcrecordid>eNp1kL1PwzAQxS0EoqWwM6FKLCwB3yXxB1tV8SUFwQBz5NoOpGriYidD_3sctYBUieXs8_vds_0IOQd6DcD5DVDGhGQSqQSggh-QMciMJpix_DDuo5wM-oichLCklCJDOCajFDFNmZRjcjvrvFt_1nqqWjN9rrV3ehO62Bd1U3fWTF-9C50aTmbGtk4rr-vWNSqckqNKrYI9260T8n5_9zZ_TIqXh6f5rEh0CqJLFoiKV0YYygRj2kCuQMlUS2s0cqU0AAqscqrzKFLDQVMjxVByYNymE3K19V1799Xb0JVNHbRdrVRrXR9KTEXOIRYZ0cs9dOl638bXlZhhJriUKCJFt1T8bAjeVuXa143ymxJoOeRa7ucaRy52xv2iseZ34CfICCRbIKgP-3frv4bfv_5-Rg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2424879928</pqid></control><display><type>article</type><title>Atrophic and Microcystic Limited Prostatic Adenocarcinomas</title><source>SAGE</source><creator>Arista-Nasr, Julian ; Martinez-Benitez, Braulio ; Mendez-Cano, Victor ; Albores-Saavedra, Jorge</creator><creatorcontrib>Arista-Nasr, Julian ; Martinez-Benitez, Braulio ; Mendez-Cano, Victor ; Albores-Saavedra, Jorge</creatorcontrib><description>Atrophic carcinoma and microcystic carcinoma have previously been classified as variants of conventional acinar adenocarcinoma. In this article, we studied 4 cases of atrophic carcinoma and 4 cases of limited microcystic carcinoma. We found an incidence of 0.8% in 250 needle prostatic biopsies and 1.3% of atrophic carcinoma in 150 radical prostatectomies. Microcystic carcinomas were found in 3 prostatectomies (1.2%) and in 1 needle biopsy (0.67%). The useful histological criteria for atrophic carcinoma included the irregular disposition of the glands, infiltrative pattern, “rigid” luminal borders, and intraluminal secretions. Cytological changes included scant cytoplasm, nucleomegaly, hyperchromatic nuclei, and visible nucleoli. The glands of the microcystic carcinoma differ from the benign glands because the malignant ones show a markedly greater dilatation and exhibit rigidity of glandular lumens. In some cases of microcystic carcinoma, the nuclei were flattened, small, and hyperchromatic; therefore, they can be difficult to recognize as malignant.</description><identifier>ISSN: 1066-8969</identifier><identifier>EISSN: 1940-2465</identifier><identifier>DOI: 10.1177/1066896920911087</identifier><identifier>PMID: 32233699</identifier><language>eng</language><publisher>Los Angeles, CA: SAGE Publications</publisher><subject>Adenocarcinoma - diagnosis ; Adenocarcinoma - pathology ; Biopsy ; Biopsy, Needle ; Cancer surgery ; Humans ; Male ; Pathology ; Prostate cancer ; Prostatectomy ; Prostatic Neoplasms - diagnosis ; Prostatic Neoplasms - pathology ; Urological surgery</subject><ispartof>International journal of surgical pathology, 2020-09, Vol.28 (6), p.584-589</ispartof><rights>The Author(s) 2020</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c318t-b22a7fd8d06866cd15a1a93c9edc27aac11282f50c5cd10d71c0d98c0d95167e3</cites><orcidid>0000-0002-8925-8651</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925,79364</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32233699$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Arista-Nasr, Julian</creatorcontrib><creatorcontrib>Martinez-Benitez, Braulio</creatorcontrib><creatorcontrib>Mendez-Cano, Victor</creatorcontrib><creatorcontrib>Albores-Saavedra, Jorge</creatorcontrib><title>Atrophic and Microcystic Limited Prostatic Adenocarcinomas</title><title>International journal of surgical pathology</title><addtitle>Int J Surg Pathol</addtitle><description>Atrophic carcinoma and microcystic carcinoma have previously been classified as variants of conventional acinar adenocarcinoma. In this article, we studied 4 cases of atrophic carcinoma and 4 cases of limited microcystic carcinoma. We found an incidence of 0.8% in 250 needle prostatic biopsies and 1.3% of atrophic carcinoma in 150 radical prostatectomies. Microcystic carcinomas were found in 3 prostatectomies (1.2%) and in 1 needle biopsy (0.67%). The useful histological criteria for atrophic carcinoma included the irregular disposition of the glands, infiltrative pattern, “rigid” luminal borders, and intraluminal secretions. Cytological changes included scant cytoplasm, nucleomegaly, hyperchromatic nuclei, and visible nucleoli. The glands of the microcystic carcinoma differ from the benign glands because the malignant ones show a markedly greater dilatation and exhibit rigidity of glandular lumens. In some cases of microcystic carcinoma, the nuclei were flattened, small, and hyperchromatic; therefore, they can be difficult to recognize as malignant.</description><subject>Adenocarcinoma - diagnosis</subject><subject>Adenocarcinoma - pathology</subject><subject>Biopsy</subject><subject>Biopsy, Needle</subject><subject>Cancer surgery</subject><subject>Humans</subject><subject>Male</subject><subject>Pathology</subject><subject>Prostate cancer</subject><subject>Prostatectomy</subject><subject>Prostatic Neoplasms - diagnosis</subject><subject>Prostatic Neoplasms - pathology</subject><subject>Urological surgery</subject><issn>1066-8969</issn><issn>1940-2465</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp1kL1PwzAQxS0EoqWwM6FKLCwB3yXxB1tV8SUFwQBz5NoOpGriYidD_3sctYBUieXs8_vds_0IOQd6DcD5DVDGhGQSqQSggh-QMciMJpix_DDuo5wM-oichLCklCJDOCajFDFNmZRjcjvrvFt_1nqqWjN9rrV3ehO62Bd1U3fWTF-9C50aTmbGtk4rr-vWNSqckqNKrYI9260T8n5_9zZ_TIqXh6f5rEh0CqJLFoiKV0YYygRj2kCuQMlUS2s0cqU0AAqscqrzKFLDQVMjxVByYNymE3K19V1799Xb0JVNHbRdrVRrXR9KTEXOIRYZ0cs9dOl638bXlZhhJriUKCJFt1T8bAjeVuXa143ymxJoOeRa7ucaRy52xv2iseZ34CfICCRbIKgP-3frv4bfv_5-Rg</recordid><startdate>202009</startdate><enddate>202009</enddate><creator>Arista-Nasr, Julian</creator><creator>Martinez-Benitez, Braulio</creator><creator>Mendez-Cano, Victor</creator><creator>Albores-Saavedra, Jorge</creator><general>SAGE Publications</general><general>SAGE PUBLICATIONS, INC</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-8925-8651</orcidid></search><sort><creationdate>202009</creationdate><title>Atrophic and Microcystic Limited Prostatic Adenocarcinomas</title><author>Arista-Nasr, Julian ; Martinez-Benitez, Braulio ; Mendez-Cano, Victor ; Albores-Saavedra, Jorge</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c318t-b22a7fd8d06866cd15a1a93c9edc27aac11282f50c5cd10d71c0d98c0d95167e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Adenocarcinoma - diagnosis</topic><topic>Adenocarcinoma - pathology</topic><topic>Biopsy</topic><topic>Biopsy, Needle</topic><topic>Cancer surgery</topic><topic>Humans</topic><topic>Male</topic><topic>Pathology</topic><topic>Prostate cancer</topic><topic>Prostatectomy</topic><topic>Prostatic Neoplasms - diagnosis</topic><topic>Prostatic Neoplasms - pathology</topic><topic>Urological surgery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Arista-Nasr, Julian</creatorcontrib><creatorcontrib>Martinez-Benitez, Braulio</creatorcontrib><creatorcontrib>Mendez-Cano, Victor</creatorcontrib><creatorcontrib>Albores-Saavedra, Jorge</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of surgical pathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Arista-Nasr, Julian</au><au>Martinez-Benitez, Braulio</au><au>Mendez-Cano, Victor</au><au>Albores-Saavedra, Jorge</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Atrophic and Microcystic Limited Prostatic Adenocarcinomas</atitle><jtitle>International journal of surgical pathology</jtitle><addtitle>Int J Surg Pathol</addtitle><date>2020-09</date><risdate>2020</risdate><volume>28</volume><issue>6</issue><spage>584</spage><epage>589</epage><pages>584-589</pages><issn>1066-8969</issn><eissn>1940-2465</eissn><abstract>Atrophic carcinoma and microcystic carcinoma have previously been classified as variants of conventional acinar adenocarcinoma. In this article, we studied 4 cases of atrophic carcinoma and 4 cases of limited microcystic carcinoma. We found an incidence of 0.8% in 250 needle prostatic biopsies and 1.3% of atrophic carcinoma in 150 radical prostatectomies. Microcystic carcinomas were found in 3 prostatectomies (1.2%) and in 1 needle biopsy (0.67%). The useful histological criteria for atrophic carcinoma included the irregular disposition of the glands, infiltrative pattern, “rigid” luminal borders, and intraluminal secretions. Cytological changes included scant cytoplasm, nucleomegaly, hyperchromatic nuclei, and visible nucleoli. The glands of the microcystic carcinoma differ from the benign glands because the malignant ones show a markedly greater dilatation and exhibit rigidity of glandular lumens. In some cases of microcystic carcinoma, the nuclei were flattened, small, and hyperchromatic; therefore, they can be difficult to recognize as malignant.</abstract><cop>Los Angeles, CA</cop><pub>SAGE Publications</pub><pmid>32233699</pmid><doi>10.1177/1066896920911087</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0002-8925-8651</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1066-8969 |
ispartof | International journal of surgical pathology, 2020-09, Vol.28 (6), p.584-589 |
issn | 1066-8969 1940-2465 |
language | eng |
recordid | cdi_proquest_miscellaneous_2385713859 |
source | SAGE |
subjects | Adenocarcinoma - diagnosis Adenocarcinoma - pathology Biopsy Biopsy, Needle Cancer surgery Humans Male Pathology Prostate cancer Prostatectomy Prostatic Neoplasms - diagnosis Prostatic Neoplasms - pathology Urological surgery |
title | Atrophic and Microcystic Limited Prostatic Adenocarcinomas |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T10%3A16%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Atrophic%20and%20Microcystic%20Limited%20Prostatic%20Adenocarcinomas&rft.jtitle=International%20journal%20of%20surgical%20pathology&rft.au=Arista-Nasr,%20Julian&rft.date=2020-09&rft.volume=28&rft.issue=6&rft.spage=584&rft.epage=589&rft.pages=584-589&rft.issn=1066-8969&rft.eissn=1940-2465&rft_id=info:doi/10.1177/1066896920911087&rft_dat=%3Cproquest_cross%3E2424879928%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c318t-b22a7fd8d06866cd15a1a93c9edc27aac11282f50c5cd10d71c0d98c0d95167e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2424879928&rft_id=info:pmid/32233699&rft_sage_id=10.1177_1066896920911087&rfr_iscdi=true |